Overview of the TB-500 + BPC-157 Blend This specialized, multi-peptide research complex is engineered for advanced in-vitro and biochemical laboratory applications. By combining an actin-sequestering peptide (TB-500) with a gastric-derived repair sequence (BPC-157), this blend provides researchers with a unique, pre-formulated tool to evaluate multi-pathway interactions within controlled experimental environments.
Composition (Per Vial):
-
TB-500 (Thymosin Beta-4 Fragment) — 5mg: A synthetic heptapeptide studied for its actin-sequestering properties, which are critical to cellular mobility, angiogenesis, and structural modeling.
-
BPC-157 — 5mg: A synthetic 15-amino acid sequence evaluated for its distinct influence on cellular repair mechanisms and inflammatory pathway modulation.
Research Applications:
-
Synergistic Pathway Analysis: Evaluating the biochemical responses when matrix-remodeling peptides and actin-upregulating peptides are introduced to cellular models simultaneously.
-
Cellular Migration & ECM Modeling: Investigating extracellular matrix dynamics and cellular movement in isolated tissue assays.
-
Tissue Repair Studies: Analyzing cellular responses in muscle, ligament, and endothelial repair models.
The Secra Labs Quality Guarantee This complex formulation has been synthesized to the highest clinical standards. Every batch of this Secra Labs blend undergoes rigorous independent HPLC and MS testing to ensure a minimum purity threshold of 99% across both active compounds, guaranteeing highly stable, reproducible results for your laboratory assays.
Disclaimer: This product is sold strictly for in-vitro laboratory research, development, and analytical purposes. It is not a drug, cosmetic, or food additive. It has not been evaluated by the FDA and is strictly prohibited from human or animal consumption, injection, or dosing.
Reviews
There are no reviews yet.